Quell 2.0

By Dave Muoio 02:22 pm August 9, 2019
Following another rough quarter, NeuroMetrix has sought outside help in an effort to restructure its business and is pivoting away from a direct-to-consumer business model for its wearable pain relief platform, Quell. “NeuroMetrix has good product lines and technology, and more broadly, the company has real value,” Dr. Shai Gozani, CEO and president of NeuroMetrix, told investors in a recent...
By MobiHealthNews 04:06 pm September 5, 2018
The end of an error. The Wall Street Journal reports that Theranos, the once-promising blood testing startup now plagued by scandals and lawsuits, will soon be shutting its doors for good. In a letter to shareholders obtained by the Journal, CEO and General Counsel David Taylor wrote that the company’s attempts to negotiate a sale transaction did not bear fruit, and that the company is in default...